News - Surgical and Supplies

AEGEA Medical completes enrollment in PACE MX

AEGEA Medical announced that it has completed enrollment in the Post-Ablation Cavity Evaluation Mexico (PACE MX) clinical study of women who previously underwent endometrial ablation as part of a pivotal trial of AEGEA’s Mara Water Vapor Ablation Treatment.

RMS Medical Products receives FDA 510(k) clearance for subcutaneous needle sets

Repro Med Systems, dba RMS Medical Products has received 510(k) clearance from the US Food and Drug Administration (FDA) for its HIgh-Flo Super26 subcutaneous needle sets (Super 26 Needle Sets).

Medline to buy AngioDynamics’ Namic fluid management business for $167.5m

Healthcare firm Medline Industries has agreed to acquire Namic fluid management business from AngioDynamics for $167.5m.

Equashield and Leaf Medical expand partnership to improve hospital worker safety in the UK

Equashield announced an expansion of its exclusive partnership with Leaf Medical LTD to distribute its manual and automated Closed System Transfer Device (CSTD) solutions for the safe compounding and administration of hazardous drugs.

Stryker introduces Surpass Evolve Flow Diverter to treat brain aneurysms

Medical technology firm Stryker has introduced next generation Surpass Evolve Flow Diverter for the treatment of brain aneurysms.

Ajax Health secures $85m funding to advance medical device innovations

Ajax Health, a medical device venture, has secured more than $85m in latest funding round led by HealthQuest Capital, with participation from Aisling Capital and Polaris Partners.

Avinger secures FDA approval for Pantheris SV atherectomy system

Avinger, a developer of Peripheral Artery Disease (PAD) diagnosis and treatment systems, has received 510(k) clearance from the US Food & Drug Administration (FDA) for its Pantheris Small Vessel (SV) image-guided atherectomy system.

Latest aesthetic medical devices at Aesthetic & Anti-Aging Medicine World Congress

Organised by EuroMediCom, medical experts attended the 17th Aesthetic & Anti-Aging Medicine World Congress to showcase future aesthetic medical devices

Signum Surgical secures €3.6m in grant funding to support launch of therapy for patients with common colorectal disease

Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, has announced the company has secured €3.6m ($4m) through two grant funding awards.